Product Code: GVR-1-68038-366-9
Medical Devices Analytical Testing Outsourcing Market Summary
The global medical devices analytical testing outsourcing market size was valued at USD 7.1 billion in 2025 and is projected to grow from USD 7.6 billion in 2026 to USD 13.0 billion by 2033, at a CAGR of 8.0% from 2026 to 2033. North America dominated the market, accounting for the largest share of 39.2% in 2025. The medical devices analytical testing outsourcing industry is experiencing steady growth, driven by increasingly stringent regulatory requirements for device safety and performance, rising complexity of medical device technologies, growing product development activities across diagnostic and therapeutic devices, increasing demand for biocompatibility and material characterization studies, and the continued outsourcing of specialized testing services to third-party laboratories.
Medical device manufacturers are increasingly relying on external analytical testing providers to support product development, regulatory submissions, quality assurance programs, and post-market compliance activities while optimizing operational costs and accelerating time-to-market. The growing complexity of medical devices remains a key factor supporting market expansion. Advanced implantable devices, combination products, in vitro diagnostic (IVD) systems, minimally invasive surgical devices, and digitally enabled medical technologies require extensive analytical testing throughout the product lifecycle. Regulatory authorities increasingly require comprehensive evaluations related to chemical characterization, extractables and leachables, material composition, biocompatibility, sterilization validation, packaging integrity, and shelf-life performance.
As a result, manufacturers are seeking specialized analytical testing partners with advanced instrumentation, technical expertise, and regulatory experience to meet evolving compliance requirements. The increasing volume of regulatory submissions and product approvals continues to generate demand for outsourced analytical testing services. Medical device companies are expanding testing programs to address requirements under evolving regulatory frameworks, including risk-based assessments, material safety evaluations, and performance verification studies. Outsourcing enables manufacturers to access specialized capabilities and accredited laboratory infrastructure without substantial investments in internal testing facilities, thereby improving development efficiency and regulatory readiness.
Global Medical Devices Analytical Testing Outsourcing Market Report Segmentation
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical devices analytical testing outsourcing market report based on service, therapeutic area, end use, device type, and region:
- Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Extractable and Leachable
- Material Characterization
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Other Tests
- Therapeutic Area Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Cardiology
- Diagnostic Imaging
- Orthopedic
- IVD
- Ophthalmic
- General & Plastic Surgery
- Drug Delivery
- Endoscopy
- Dental
- Diabetes Care
- Others
- End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Hospital
- Equipment
- Consumables
- Syringes
- Wound Care
- Others
- Others
- Device Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- Reprocessed Devices
- Others
- Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
- Qatar
- Oman
Table of Contents
Chapter 1. Research Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Service
- 1.2.2. Therapeutic Area
- 1.2.3. End Use
- 1.2.4. Device Type
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information Or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.7.2. Top-Down Analysis
- 1.7.3. Bottom-Up Approach
- 1.7.4. Multivariate Analysis
- 1.8. List Of Secondary Sources
- 1.9. List Of Abbreviations
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Medical Devices Analytical Testing Outsourcing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Technology Landscape
- 3.4. Pricing Model Analysis
- 3.5. Tariff Impact Analysis
- 3.6. Value Chain Analysis
- 3.6.1. Supply Trends
- 3.6.2. Demand Trends
- 3.7. Market Analysis Tools
- 3.7.1. Porter's Five Force Analysis
- 3.7.2. PESTEL by SWOT Analysis
Chapter 4. Medical Devices Analytical Testing Outsourcing Market: Service Estimates & Trend Analysis
- 4.1. Medical Devices Analytical Testing Outsourcing Market, By Service: Segment Dashboard
- 4.2. Medical Devices Analytical Testing Outsourcing Market, By Service: Movement Analysis
- 4.3. Medical Devices Analytical Testing Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million/Billion)
- 4.4. Extractable and Leachable
- 4.4.1. Extractable and Leachable Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.5. Material Characterization
- 4.5.1. Material Characterization Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.6. Physical Testing
- 4.6.1. Physical Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.7. Bioburden Testing
- 4.7.1. Bioburden Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.8. Sterility Testing
- 4.8.1. Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 4.9. Other Tests
- 4.9.1. Other Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 5. Medical Devices Analytical Testing Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
- 5.1. Medical Devices Analytical Testing Outsourcing Market, By Therapeutic Area: Segment Dashboard
- 5.2. Medical Devices Analytical Testing Outsourcing Market, By Therapeutic Area: Movement Analysis
- 5.3. Medical Devices Analytical Testing Outsourcing Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million/Billion)
- 5.4. Cardiology
- 5.4.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.5. Diagnostic Imaging
- 5.5.1. Diagnostic Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.6. Orthopedic
- 5.6.1. Orthopedic Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.7. IVD
- 5.7.1. IVD Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.8. Ophthalmic
- 5.8.1. Ophthalmic Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.9. General & Plastic Surgery
- 5.9.1. General & Plastic Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.10. Drug Delivery
- 5.10.1. Drug Delivery Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.11. Endoscopy
- 5.11.1. Endoscopy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.12. Dental
- 5.12.1. Dental Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.13. Diabetes Care
- 5.13.1. Diabetes Care Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.14. Others
- 5.14.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 6. Medical Devices Analytical Testing Outsourcing Market: End Use Estimates & Trend Analysis
- 6.1. Medical Devices Analytical Testing Outsourcing Market, By End Use: Segment Dashboard
- 6.2. Medical Devices Analytical Testing Outsourcing Market, By End Use: Movement Analysis
- 6.3. Medical Devices Analytical Testing Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million/Billion)
- 6.4. Hospital
- 6.4.1. Hospital Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.4.2. Equipment
- 6.4.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.4.3. Consumables
- 6.4.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.4.3.2. Syringes
- 6.4.3.2.1. Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.4.3.3. Wound Care
- 6.4.3.3.1. Wound Care Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.4.3.4. Others
- 6.4.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 6.5. Others
- 6.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 7. Medical Devices Analytical Testing Outsourcing Market: Device Type Estimates & Trend Analysis
- 7.1. Medical Devices Analytical Testing Outsourcing Market, By Device Type: Segment Dashboard
- 7.2. Medical Devices Analytical Testing Outsourcing Market, By Device Type: Movement Analysis
- 7.3. Medical Devices Analytical Testing Outsourcing Market Estimates & Forecasts, By Device Type, 2021 - 2033 (USD Million/Billion)
- 7.4. Reprocessed Devices
- 7.4.1. Reprocessed Devices Market Estimates & Forecasts, By Device Type, 2021 - 2033 (USD Million/Billion)
- 7.4.2. Hospital
- 7.4.2.1. Hospital Market Estimates & Forecasts, By Device Type, 2021 - 2033 (USD Million/Billion)
- 7.4.3. Others
- 7.4.3.1. Others Market Estimates & Forecasts, By Device Type, 2021 - 2033 (USD Million/Billion)
- 7.5. Others
- 7.5.1. Others Market Estimates & Forecasts, By Device Type, 2021 - 2033 (USD Million/Billion)
Chapter 8. Medical Devices Analytical Testing Outsourcing Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market Share Analysis, 2025 & 2033
- 8.3. North America
- 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.3.2. U.S
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4. Europe
- 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Framework
- 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.5. Australia
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.6. Thailand
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.5.7. South Korea
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.6. Latin America
- 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7. MEA
- 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.3. UAE
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.4. Saudi Arabia
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.6. Qatar
- 8.7.6.1. Key Country Dynamics
- 8.7.6.2. Competitive Scenario
- 8.7.6.3. Regulatory Framework
- 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
- 8.7.7. Oman
- 8.7.7.1. Key Country Dynamics
- 8.7.7.2. Competitive Scenario
- 8.7.7.3. Regulatory Framework
- 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million/Billion)
Chapter 9. Competitive Landscape
- 9.1. Key Participant Categorization
- 9.1.1. Market Leaders
- 9.1.2. Emerging Players
- 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
- 9.3. Company Profiles
- 9.3.1. SGS Societe Generale de Surveillance SA
- 9.3.1.1. Company Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Service Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Toxikon, Inc. (Laboratory Corporation of America Holdings)
- 9.3.2.1. Company Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Service Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Eurofins Scientific
- 9.3.3.1. Company Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Service Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Pace Analytical Services, LLC
- 9.3.4.1. Company Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Service Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Intertek Group plc
- 9.3.5.1. Company Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Service Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Wuxi AppTec
- 9.3.6.1. Company Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Service Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. North American Science Associates, LLC
- 9.3.7.1. Company Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Service Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Envigo (Inotiv)
- 9.3.8.1. Company Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Service Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Charles River Laboratories
- 9.3.9.1. Company Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Service Benchmarking
- 9.3.9.4. Strategic Initiatives